A blue diabetes ribbon is featured with the words "celebrating 2022 a message to our TrialNet family"
Media Release
Read more
TrialNet Chair Dr. Kevan Herold reflects on 2022— “a landmark year for T1D research”
TrialNet Chair Kevan C. Herold, MD, reflects on advances in type 1 diabetes research and the need to continue testing promising treatments.
Dear TrialNet Family,
